Harare, (New Ziana) – The Medicines Control Authority of Zimbabwe (MCAZ) has launched its Client Service Charter as part of its continued commitment to transparency, accountability, and high-quality service delivery.
In a statement on Tuesday, the MCAZ said the Charter was crafted to clearly outline what stakeholders can expect when engaging with it, including defined service standards and timelines across key regulatory functions.
These include, among others, import permits, export permits, registration of medicines, licensing of premises, complaint handling, and inspection at ports of entry.
“The Client Service Charter was developed to promote predictability and consistency in regulatory processes, strengthen stakeholder confidence and trust, as well as improve accountability and performance monitoring.
“It will also align MCAZ operations with ISO 9001:2015 Quality Management principles. Through this Charter, MCAZ reaffirms its commitment to providing fair, timely, professional, and ethical regulatory services in support of public health and the national medicines supply system,” MCAZ public relations and communications manager Davison Kaiyo said.
The MCAZ is a statutory body established by an Act of Parliament, the Medicines and Allied Substances Control Act (MASCA), and is a successor of the Drugs Control Council (DCC) and the Zimbabwe Regional Drug Control Laboratory (ZRDCL).
New Ziana